Lifecare ASA: Mandatory notification of trade

Posted: 13/03/2026
Lifecare ASA: Mandatory notification of trade

The Company has been informed that Hannibal Invest AS, a company closely associated with Hans Hekland, board member and primary insider of Lifecare ASA, has sold 211,856 shares in the Company at a price of NOK 0.4456 per share.

Following this transaction, Hannibal Invest AS holds 746,302 shares and 705,196 Warrants Series 2 in the Company.

About us
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare’s focus is to bring the next generation of Continuous Glucose Monitoring systems to market. Lifecare enables osmotic pressure as sensing principle. Lifecare’s sensor technology is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-03-13 23:37 CET.

Attachments
Lifecare ASA: Mandatory notification of trade
260313 PDMR Attachment – Hannibal Invest Shares

Lifecare ASA: Mandatory notification of trade
260313 PDMR Attachment – Hannibal Invest Shares